Arbaclofen placarbil (XP19986)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Arbaclofen placarbil (XP19986), covering 2016-09-14 to 2021-02-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD) [Phase 2]